Granules India Limited (BOM:532482)
565.30
-9.25 (-1.61%)
At close: Oct 31, 2025
Granules India Employees
Granules India had 4,066 employees as of March 31, 2025. The number of employees increased by 9 or 0.22% compared to the previous year.
Employees
4,066
Change (1Y)
9
Growth (1Y)
0.22%
Revenue / Employee
11.10M INR
Profits / Employee
1.18M INR
Market Cap
137.18B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 4,066 | 9 | 0.22% |
| Mar 31, 2024 | 4,057 | 407 | 11.15% |
| Mar 31, 2023 | 3,650 | -36 | -0.98% |
| Mar 31, 2022 | 3,686 | 317 | 9.41% |
| Mar 31, 2021 | 3,369 | 340 | 11.22% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Tata Consultancy Services | 607,979 |
| Reliance Industries | 403,303 |
| Infosys | 323,578 |
| State Bank of India | 236,226 |
| HDFC Bank | 214,521 |
| ICICI Bank | 182,665 |
| Life Insurance Corporation of India | 91,606 |
| Bajaj Finance | 64,092 |
Granules India News
- 2 months ago - Granules India Q1 Results: Revenue jumps 2.56% YoY to Rs 1,210.11 crore, net profit falls 16.37% YoY - Business Upturn
- 3 months ago - Granules India’s Hyderabad unit receives one US FDA observation after Pre-Approval Inspection - Business Upturn
- 3 months ago - Granules India CEO Kandiraju Venkata Sitaram Rao resigns, effective July 31 - Business Upturn
- 4 months ago - Granules India clears US FDA Pre-Approval Inspection with zero observations - Business Upturn
- 4 months ago - Granules India’s Bonthapally facility completes US FDA inspection with one observation - Business Upturn
- 4 months ago - Pharma scrips fall on Trump tariff threat - The Times of India
- 8 months ago - Granules India shares drop nearly 3% amid US FDA warning letter - Business Upturn
- 8 months ago - Granules India shares drop 3.6% after receiving US FDA warning letter for Gagillapur facility - Business Upturn